BAK linked to ocular surface damage in animal studies

Article

Prostaglandin analogues preserved with benzalkonium chloride (BAK) can cause more extensive loss of goblet cells and a breakdown of cell-cell adhesions, which could increase the risk of ocular surface disease, according to findings from a pair of studies conducted in rabbits.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Osamah Saeedi, MD, MS, at ARVO 2024
Dr Nir Shoham Hazon, Director, Miramichi EyeNB Centre of Excellence, New Brunswick, Canada
Paul Harasymowycz, MD
Ms Neeru Vallabh on a virtual call with Ophthalmology Times Europe
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Related Content
A cell being injected by a syringe. Image credit: ©Corona Borealis – stock.adobe.com

Trinity team’s gene therapy offers promising glaucoma and AMD treatment

Martin David Harp
September 9th 2024
Article

Research by investigators at Trinity College in Dublin, Ireland shows how the gene therapy conferred significant protection for retinal ganglion cells

An ophthalmologist conducts an exam on an elderly female patient. Image credit: ©Yakobchuk Olena – stock.adobe.com

Why the future of glaucoma care is in the operating room

Hattie Hayes; Reviewed by Norbert Pfeiffer, MD
August 14th 2024
Article

Smaller surgeries, in greater numbers, await new glaucoma specialists

A collection of purple lasers shoot from a central light source. Image credit: ©monsifdx – stock.adobe.com

ViaLase Laser receives CE Mark, announces first EU distribution partners

Hattie Hayes
July 30th 2024
Article

Femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) received approval for patients in Europe with primary open-angle glaucoma

Cells under a microscope. They are connected by red lines representing charted growth data. Image credit: ©Naphatson – stock.adobe.com

Insights into neovascular glaucoma: Pathogenesis and detection of diabetic retinopathy

Palla Deepika
July 1st 2024
Article

Management of neovascular glaucoma focuses on decreasing retinal ischemia through panretinal photocoagulation and the injection of anti-VEGF agents

Figure 2. Sample collection and analysis. The metabolomics workflow. (Figure data courtesy of Neeru Vallabh, MBBS, FRCOphth, PhD)

Metabolomics and the molecular approach to glaucoma diagnosis

Lynda Charters; Reviewed by Neeru Vallabh, MBBS, FRCOphth, PhD
June 12th 2024
Article

Metabolomics reflects the physiological state of a tissue and provides information about interactions between genetics, environment and lifestyle

A web of graphs, digital graphics and binary code visualising data. Image credit: ©Summit Art Creations – stock.adobe.com

Safety and efficacy findings from the XEN45 glaucoma implant

Lynda Charters
June 4th 2024
Article

Investigators assessed the XEN45 implant alone and in combination with phacoemulsification

© 2024 MJH Life Sciences

All rights reserved.